Scientific References (External Links) Drug Testing and Analysis: Detection and in vitro metabolism of AOD9604 View Study Endocrinology: The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice View Study Hormone Research: Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone View Study Current Opinion in Investigational Drugs: AOD-9604 Metabolic View Study
"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with obesity: a randomised, double-blind, placebo- and active-controlled, parallel-group, phase 2 trial." The Lancet, vol
10.1177/1099800414555411 Biol
In some embodiments, the auris-acceptable penetration enhancer is a surfactant comprising an alkyl-glycoside wherein the alkyl glycoside is tetradecyl--D-maltoside
Patients often experience a gradual tightening of the midsection, improved energy stability, and enhanced workout recovery